

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 6.17500025 |
| 2 | vocalization behavior (GO:0071625) | 6.07927984 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.96161114 |
| 4 | glutamate secretion (GO:0014047) | 5.44002494 |
| 5 | neuron cell-cell adhesion (GO:0007158) | 5.40218852 |
| 6 | locomotory exploration behavior (GO:0035641) | 5.10291388 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.99340994 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.98119623 |
| 9 | neuronal action potential propagation (GO:0019227) | 4.97213687 |
| 10 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.96811414 |
| 11 | neurotransmitter secretion (GO:0007269) | 4.95936445 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.94976066 |
| 13 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.89243830 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.77644159 |
| 15 | synaptic vesicle maturation (GO:0016188) | 4.73756948 |
| 16 | protein localization to synapse (GO:0035418) | 4.63631252 |
| 17 | gamma-aminobutyric acid transport (GO:0015812) | 4.60183364 |
| 18 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.35443166 |
| 19 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.34160693 |
| 20 | exploration behavior (GO:0035640) | 4.29540895 |
| 21 | regulation of synaptic vesicle transport (GO:1902803) | 4.27468621 |
| 22 | positive regulation of heat generation (GO:0031652) | 4.25988349 |
| 23 | neuron-neuron synaptic transmission (GO:0007270) | 4.24505831 |
| 24 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.11699525 |
| 25 | neurotransmitter transport (GO:0006836) | 4.08178408 |
| 26 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.06119398 |
| 27 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.02639032 |
| 28 | positive regulation of synapse maturation (GO:0090129) | 4.02395339 |
| 29 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.98432149 |
| 30 | synaptic transmission, glutamatergic (GO:0035249) | 3.98325088 |
| 31 | glutamate receptor signaling pathway (GO:0007215) | 3.97151790 |
| 32 | proline transport (GO:0015824) | 3.93899293 |
| 33 | cellular response to ATP (GO:0071318) | 3.90097556 |
| 34 | eosinophil chemotaxis (GO:0048245) | 3.81597091 |
| 35 | regulation of neurotransmitter levels (GO:0001505) | 3.81146880 |
| 36 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.80615220 |
| 37 | long-term memory (GO:0007616) | 3.79837267 |
| 38 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.76704203 |
| 39 | kynurenine metabolic process (GO:0070189) | 3.73531452 |
| 40 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.70626902 |
| 41 | oligosaccharide catabolic process (GO:0009313) | 3.68707501 |
| 42 | regulation of heat generation (GO:0031650) | 3.63977349 |
| 43 | regulation of synapse structural plasticity (GO:0051823) | 3.62861591 |
| 44 | neuron recognition (GO:0008038) | 3.61849301 |
| 45 | long-term synaptic potentiation (GO:0060291) | 3.58730479 |
| 46 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.58212119 |
| 47 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.57454795 |
| 48 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.56763045 |
| 49 | regulation of fever generation (GO:0031620) | 3.53812276 |
| 50 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.53603524 |
| 51 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.53603524 |
| 52 | synaptic vesicle endocytosis (GO:0048488) | 3.48367032 |
| 53 | detection of calcium ion (GO:0005513) | 3.45729875 |
| 54 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.45429471 |
| 55 | layer formation in cerebral cortex (GO:0021819) | 3.45275256 |
| 56 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.45194788 |
| 57 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.45117952 |
| 58 | positive regulation of membrane potential (GO:0045838) | 3.44957693 |
| 59 | regulation of postsynaptic membrane potential (GO:0060078) | 3.42186941 |
| 60 | transmission of nerve impulse (GO:0019226) | 3.41155401 |
| 61 | indole-containing compound catabolic process (GO:0042436) | 3.36894879 |
| 62 | indolalkylamine catabolic process (GO:0046218) | 3.36894879 |
| 63 | tryptophan catabolic process (GO:0006569) | 3.36894879 |
| 64 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.36755328 |
| 65 | regulation of synaptic plasticity (GO:0048167) | 3.36622017 |
| 66 | positive regulation of prostaglandin secretion (GO:0032308) | 3.36203545 |
| 67 | eosinophil migration (GO:0072677) | 3.35612579 |
| 68 | response to histamine (GO:0034776) | 3.35427624 |
| 69 | startle response (GO:0001964) | 3.34859282 |
| 70 | transferrin transport (GO:0033572) | 3.31793527 |
| 71 | regulation of prostaglandin secretion (GO:0032306) | 3.30920388 |
| 72 | regulation of vesicle fusion (GO:0031338) | 3.30404454 |
| 73 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.30362620 |
| 74 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.29943998 |
| 75 | presynaptic membrane assembly (GO:0097105) | 3.28589858 |
| 76 | regulation of neurotransmitter secretion (GO:0046928) | 3.25566132 |
| 77 | regulation of synapse maturation (GO:0090128) | 3.23980347 |
| 78 | behavioral response to cocaine (GO:0048148) | 3.22964758 |
| 79 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.22407009 |
| 80 | synaptic transmission, dopaminergic (GO:0001963) | 3.22136741 |
| 81 | mating behavior (GO:0007617) | 3.20529240 |
| 82 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.19809945 |
| 83 | negative regulation of amino acid transport (GO:0051956) | 3.18824945 |
| 84 | synaptic transmission (GO:0007268) | 3.17820163 |
| 85 | cellular potassium ion homeostasis (GO:0030007) | 3.16585750 |
| 86 | neuromuscular process controlling posture (GO:0050884) | 3.16412667 |
| 87 | response to cocaine (GO:0042220) | 3.14841234 |
| 88 | synapse assembly (GO:0007416) | 3.14730535 |
| 89 | establishment of synaptic vesicle localization (GO:0097480) | 3.13604116 |
| 90 | synaptic vesicle transport (GO:0048489) | 3.13604116 |
| 91 | intraspecies interaction between organisms (GO:0051703) | 3.12859235 |
| 92 | social behavior (GO:0035176) | 3.12859235 |
| 93 | postsynaptic membrane organization (GO:0001941) | 3.12288639 |
| 94 | succinate metabolic process (GO:0006105) | 3.11792557 |
| 95 | membrane depolarization (GO:0051899) | 3.10775046 |
| 96 | striatum development (GO:0021756) | 3.10448681 |
| 97 | axonal fasciculation (GO:0007413) | 3.09882662 |
| 98 | ferric iron transport (GO:0015682) | 3.09184701 |
| 99 | trivalent inorganic cation transport (GO:0072512) | 3.09184701 |
| 100 | activation of protein kinase A activity (GO:0034199) | 3.08545183 |
| 101 | regulation of neurotransmitter transport (GO:0051588) | 3.06333457 |
| 102 | learning (GO:0007612) | 3.06037009 |
| 103 | membrane depolarization during action potential (GO:0086010) | 3.05615881 |
| 104 | negative regulation of mast cell activation (GO:0033004) | 3.05557281 |
| 105 | presynaptic membrane organization (GO:0097090) | 3.04469755 |
| 106 | positive regulation of neurotransmitter transport (GO:0051590) | 3.04201691 |
| 107 | positive regulation of synapse assembly (GO:0051965) | 3.02873325 |
| 108 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.00160226 |
| 109 | dendritic spine morphogenesis (GO:0060997) | 2.99350679 |
| 110 | regulation of mononuclear cell migration (GO:0071675) | 2.99334922 |
| 111 | membrane hyperpolarization (GO:0060081) | 2.97539335 |
| 112 | regulation of synaptic transmission (GO:0050804) | 2.97297835 |
| 113 | phagosome maturation (GO:0090382) | 2.94491055 |
| 114 | positive regulation of synaptic transmission (GO:0050806) | 2.92514585 |
| 115 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.92139898 |
| 116 | regulation of glutamate secretion (GO:0014048) | 2.90854039 |
| 117 | neurotransmitter biosynthetic process (GO:0042136) | 2.86360927 |
| 118 | establishment of vesicle localization (GO:0051650) | 2.85025213 |
| 119 | negative regulation of dendrite development (GO:2000171) | 2.84486524 |
| 120 | innervation (GO:0060384) | 2.84427234 |
| 121 | cellular biogenic amine catabolic process (GO:0042402) | 2.82896481 |
| 122 | amine catabolic process (GO:0009310) | 2.82896481 |
| 123 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.81981952 |
| 124 | alanine transport (GO:0032328) | 2.79074621 |
| 125 | adult walking behavior (GO:0007628) | 2.75997326 |
| 126 | response to amphetamine (GO:0001975) | 2.73239066 |
| 127 | serotonin metabolic process (GO:0042428) | 2.72353870 |
| 128 | mitotic cell cycle arrest (GO:0071850) | 2.70780765 |
| 129 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.70099242 |
| 130 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.68641552 |
| 131 | behavioral response to nicotine (GO:0035095) | 2.68073136 |
| 132 | L-amino acid import (GO:0043092) | 2.66451330 |
| 133 | monocyte chemotaxis (GO:0002548) | 2.65052394 |
| 134 | urinary tract smooth muscle contraction (GO:0014848) | 2.63952942 |
| 135 | protein localization to cilium (GO:0061512) | 2.63013171 |
| 136 | tryptophan metabolic process (GO:0006568) | 2.61458810 |
| 137 | acidic amino acid transport (GO:0015800) | 2.59030554 |
| 138 | indole-containing compound metabolic process (GO:0042430) | 2.57908142 |
| 139 | regulation of vitamin metabolic process (GO:0030656) | 2.56051536 |
| 140 | negative regulation of interleukin-12 production (GO:0032695) | 2.53601206 |
| 141 | glycosphingolipid catabolic process (GO:0046479) | 2.51336457 |
| 142 | ganglioside metabolic process (GO:0001573) | 2.51006232 |
| 143 | response to acidic pH (GO:0010447) | 2.47823696 |
| 144 | response to ATP (GO:0033198) | 2.47352640 |
| 145 | glycerophospholipid catabolic process (GO:0046475) | 2.45687053 |
| 146 | L-glutamate transport (GO:0015813) | 2.45590099 |
| 147 | C4-dicarboxylate transport (GO:0015740) | 2.45052913 |
| 148 | calcium ion-dependent exocytosis (GO:0017156) | 2.44045648 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.50811337 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.12069400 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.22011889 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.10070318 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.06233398 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.71357341 |
| 7 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.64924767 |
| 8 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.62620773 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.57630540 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.57630540 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.55686308 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.53359633 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.49386164 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.42654665 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.41193990 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.41055994 |
| 17 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.22901640 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.22364202 |
| 19 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.21317549 |
| 20 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.13703856 |
| 21 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.10967195 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.10566579 |
| 23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.10411152 |
| 24 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.09713755 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.09458235 |
| 26 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.06625784 |
| 27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.03155145 |
| 28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.02455057 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.00657575 |
| 30 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.94654777 |
| 31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.94629452 |
| 32 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.94284389 |
| 33 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.93624217 |
| 34 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.93286637 |
| 35 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.92254011 |
| 36 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.79240288 |
| 37 | P300_19829295_ChIP-Seq_ESCs_Human | 1.75537758 |
| 38 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.66539574 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.62676762 |
| 40 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.61318684 |
| 41 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.56766954 |
| 42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.54193342 |
| 43 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.52765297 |
| 44 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.51703046 |
| 45 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.51070641 |
| 46 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.49506858 |
| 47 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.49458313 |
| 48 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.47918781 |
| 49 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.46832487 |
| 50 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.45324650 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.44873140 |
| 52 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.44317390 |
| 53 | FUS_26573619_Chip-Seq_HEK293_Human | 1.44008355 |
| 54 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.43919468 |
| 55 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.43758719 |
| 56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.43615556 |
| 57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.42681239 |
| 58 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.42116433 |
| 59 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.42020493 |
| 60 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.42004354 |
| 61 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.41921430 |
| 62 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.38773819 |
| 63 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36738303 |
| 64 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36079980 |
| 65 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.34980141 |
| 66 | STAT3_23295773_ChIP-Seq_U87_Human | 1.28535086 |
| 67 | EWS_26573619_Chip-Seq_HEK293_Human | 1.28415218 |
| 68 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.27431810 |
| 69 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.27431810 |
| 70 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.26897553 |
| 71 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.26532476 |
| 72 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.25563055 |
| 73 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.24476417 |
| 74 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21848633 |
| 75 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.21553945 |
| 76 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.20703229 |
| 77 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.20570859 |
| 78 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.19442774 |
| 79 | VDR_22108803_ChIP-Seq_LS180_Human | 1.19014933 |
| 80 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.17902585 |
| 81 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.16766393 |
| 82 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.16731562 |
| 83 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.16578505 |
| 84 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.15123336 |
| 85 | JUN_21703547_ChIP-Seq_K562_Human | 1.13977912 |
| 86 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.13914161 |
| 87 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13858141 |
| 88 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.13477647 |
| 89 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.13472594 |
| 90 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.13358889 |
| 91 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.12770374 |
| 92 | AR_19668381_ChIP-Seq_PC3_Human | 1.12440469 |
| 93 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.11940123 |
| 94 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.11241935 |
| 95 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.10832818 |
| 96 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.10173564 |
| 97 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.09500466 |
| 98 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09394205 |
| 99 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09305367 |
| 100 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.08410659 |
| 101 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08309192 |
| 102 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.07947537 |
| 103 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.06839532 |
| 104 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.06839532 |
| 105 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.06485901 |
| 106 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.05674826 |
| 107 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03524664 |
| 108 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03190823 |
| 109 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03156753 |
| 110 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.00924543 |
| 111 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99520482 |
| 112 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.98309804 |
| 113 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97747544 |
| 114 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97108690 |
| 115 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.94672837 |
| 116 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93801943 |
| 117 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.92517920 |
| 118 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92461438 |
| 119 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91902756 |
| 120 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.90604523 |
| 121 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90604523 |
| 122 | KDM2B_26808549_Chip-Seq_REH_Human | 0.90400031 |
| 123 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.90329852 |
| 124 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.90329852 |
| 125 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.89927124 |
| 126 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.87000319 |
| 127 | TP53_16413492_ChIP-PET_HCT116_Human | 0.86466428 |
| 128 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.86141610 |
| 129 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.85035444 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.67804260 |
| 2 | MP0003880_abnormal_central_pattern | 4.99026077 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.06462257 |
| 4 | MP0002822_catalepsy | 3.69273761 |
| 5 | MP0009046_muscle_twitch | 3.62253027 |
| 6 | MP0000569_abnormal_digit_pigmentation | 3.59078552 |
| 7 | MP0009745_abnormal_behavioral_response | 3.57563990 |
| 8 | MP0002064_seizures | 3.43356279 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.16671973 |
| 10 | MP0004270_analgesia | 3.12091969 |
| 11 | MP0001968_abnormal_touch/_nociception | 3.05985261 |
| 12 | MP0002735_abnormal_chemical_nociception | 2.95300477 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.84251382 |
| 14 | MP0002272_abnormal_nervous_system | 2.72703416 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.68688305 |
| 16 | MP0009840_abnormal_foam_cell | 2.61270688 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.56442709 |
| 18 | MP0002736_abnormal_nociception_after | 2.54143015 |
| 19 | MP0001486_abnormal_startle_reflex | 2.40283291 |
| 20 | MP0006276_abnormal_autonomic_nervous | 2.36537981 |
| 21 | MP0005167_abnormal_blood-brain_barrier | 2.35663236 |
| 22 | MP0001440_abnormal_grooming_behavior | 2.26859122 |
| 23 | MP0005423_abnormal_somatic_nervous | 2.23665579 |
| 24 | MP0002733_abnormal_thermal_nociception | 2.20901268 |
| 25 | MP0002067_abnormal_sensory_capabilities | 2.12731599 |
| 26 | MP0001970_abnormal_pain_threshold | 2.08737439 |
| 27 | MP0003195_calcinosis | 2.03852112 |
| 28 | MP0003172_abnormal_lysosome_physiology | 2.00088835 |
| 29 | MP0004510_myositis | 1.94411541 |
| 30 | MP0003303_peritoneal_inflammation | 1.92939774 |
| 31 | MP0000343_altered_response_to | 1.92665253 |
| 32 | MP0002184_abnormal_innervation | 1.87888627 |
| 33 | MP0004924_abnormal_behavior | 1.83005693 |
| 34 | MP0005386_behavior/neurological_phenoty | 1.83005693 |
| 35 | MP0008569_lethality_at_weaning | 1.81750129 |
| 36 | MP0002837_dystrophic_cardiac_calcinosis | 1.79833257 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.77805394 |
| 38 | MP0006082_CNS_inflammation | 1.76276074 |
| 39 | MP0002557_abnormal_social/conspecific_i | 1.76205810 |
| 40 | MP0001905_abnormal_dopamine_level | 1.76117831 |
| 41 | MP0001984_abnormal_olfaction | 1.74499245 |
| 42 | MP0002139_abnormal_hepatobiliary_system | 1.73865247 |
| 43 | MP0005646_abnormal_pituitary_gland | 1.72221416 |
| 44 | MP0001529_abnormal_vocalization | 1.71313896 |
| 45 | MP0003329_amyloid_beta_deposits | 1.70551846 |
| 46 | MP0009780_abnormal_chondrocyte_physiolo | 1.62831622 |
| 47 | MP0004858_abnormal_nervous_system | 1.62414523 |
| 48 | MP0009764_decreased_sensitivity_to | 1.62099740 |
| 49 | MP0004811_abnormal_neuron_physiology | 1.60518397 |
| 50 | MP0003122_maternal_imprinting | 1.59561880 |
| 51 | MP0000920_abnormal_myelination | 1.57616184 |
| 52 | MP0002909_abnormal_adrenal_gland | 1.56866816 |
| 53 | MP0004142_abnormal_muscle_tone | 1.56502756 |
| 54 | MP0000778_abnormal_nervous_system | 1.55140837 |
| 55 | MP0003787_abnormal_imprinting | 1.54760107 |
| 56 | MP0003950_abnormal_plasma_membrane | 1.53317218 |
| 57 | MP0001188_hyperpigmentation | 1.52870210 |
| 58 | MP0003075_altered_response_to | 1.45382485 |
| 59 | MP0000955_abnormal_spinal_cord | 1.42637325 |
| 60 | MP0003879_abnormal_hair_cell | 1.41299278 |
| 61 | MP0002066_abnormal_motor_capabilities/c | 1.40377524 |
| 62 | MP0003690_abnormal_glial_cell | 1.38296101 |
| 63 | MP0005174_abnormal_tail_pigmentation | 1.36749371 |
| 64 | MP0000015_abnormal_ear_pigmentation | 1.35842514 |
| 65 | MP0002882_abnormal_neuron_morphology | 1.30915867 |
| 66 | MP0006072_abnormal_retinal_apoptosis | 1.29866564 |
| 67 | MP0005410_abnormal_fertilization | 1.27622300 |
| 68 | MP0005058_abnormal_lysosome_morphology | 1.27417115 |
| 69 | MP0010386_abnormal_urinary_bladder | 1.26714512 |
| 70 | MP0003136_yellow_coat_color | 1.22704146 |
| 71 | MP0001502_abnormal_circadian_rhythm | 1.16697624 |
| 72 | MP0005645_abnormal_hypothalamus_physiol | 1.15529174 |
| 73 | MP0002876_abnormal_thyroid_physiology | 1.15437217 |
| 74 | MP0005253_abnormal_eye_physiology | 1.15266989 |
| 75 | MP0004885_abnormal_endolymph | 1.12650193 |
| 76 | MP0008872_abnormal_physiological_respon | 1.10783077 |
| 77 | MP0003633_abnormal_nervous_system | 1.10114949 |
| 78 | MP0001986_abnormal_taste_sensitivity | 1.07626441 |
| 79 | MP0000013_abnormal_adipose_tissue | 1.07493553 |
| 80 | MP0005310_abnormal_salivary_gland | 1.05845770 |
| 81 | MP0000371_diluted_coat_color | 1.03924622 |
| 82 | MP0003631_nervous_system_phenotype | 1.03011725 |
| 83 | MP0000751_myopathy | 0.99395229 |
| 84 | MP0002102_abnormal_ear_morphology | 0.98047971 |
| 85 | MP0002152_abnormal_brain_morphology | 0.97862719 |
| 86 | MP0002229_neurodegeneration | 0.94938239 |
| 87 | MP0009785_altered_susceptibility_to | 0.92274092 |
| 88 | MP0004742_abnormal_vestibular_system | 0.92011908 |
| 89 | MP0001963_abnormal_hearing_physiology | 0.89747684 |
| 90 | MP0005535_abnormal_body_temperature | 0.89514774 |
| 91 | MP0004147_increased_porphyrin_level | 0.88870855 |
| 92 | MP0002069_abnormal_eating/drinking_beha | 0.88246167 |
| 93 | MP0008874_decreased_physiological_sensi | 0.87414270 |
| 94 | MP0004215_abnormal_myocardial_fiber | 0.87197721 |
| 95 | MP0002638_abnormal_pupillary_reflex | 0.86579084 |
| 96 | MP0004484_altered_response_of | 0.85483124 |
| 97 | MP0004085_abnormal_heartbeat | 0.84862076 |
| 98 | MP0001177_atelectasis | 0.83828179 |
| 99 | MP0003632_abnormal_nervous_system | 0.83635258 |
| 100 | MP0002254_reproductive_system_inflammat | 0.83246650 |
| 101 | MP0005551_abnormal_eye_electrophysiolog | 0.80619200 |
| 102 | MP0008875_abnormal_xenobiotic_pharmacok | 0.79420769 |
| 103 | MP0001664_abnormal_digestion | 0.78165139 |
| 104 | MP0002419_abnormal_innate_immunity | 0.77110862 |
| 105 | MP0005394_taste/olfaction_phenotype | 0.77001375 |
| 106 | MP0005499_abnormal_olfactory_system | 0.77001375 |
| 107 | MP0001324_abnormal_eye_pigmentation | 0.76831335 |
| 108 | MP0005595_abnormal_vascular_smooth | 0.76366050 |
| 109 | MP0002095_abnormal_skin_pigmentation | 0.76300783 |
| 110 | MP0002998_abnormal_bone_remodeling | 0.76179328 |
| 111 | MP0005166_decreased_susceptibility_to | 0.75239882 |
| 112 | MP0000604_amyloidosis | 0.74357178 |
| 113 | MP0003448_altered_tumor_morphology | 0.73754822 |
| 114 | MP0003646_muscle_fatigue | 0.73217940 |
| 115 | MP0002752_abnormal_somatic_nervous | 0.73060801 |
| 116 | MP0002938_white_spotting | 0.72931532 |
| 117 | MP0002090_abnormal_vision | 0.70486764 |
| 118 | MP0009278_abnormal_bone_marrow | 0.68015852 |
| 119 | MP0004145_abnormal_muscle_electrophysio | 0.67781890 |
| 120 | MP0003634_abnormal_glial_cell | 0.67207321 |
| 121 | MP0003724_increased_susceptibility_to | 0.66892045 |
| 122 | MP0000631_abnormal_neuroendocrine_gland | 0.63683550 |
| 123 | MP0005171_absent_coat_pigmentation | 0.63588708 |
| 124 | MP0003123_paternal_imprinting | 0.60138578 |
| 125 | MP0008877_abnormal_DNA_methylation | 0.59138309 |
| 126 | MP0001943_abnormal_respiration | 0.58238362 |
| 127 | MP0004233_abnormal_muscle_weight | 0.54857015 |
| 128 | MP0002332_abnormal_exercise_endurance | 0.52772130 |
| 129 | MP0005379_endocrine/exocrine_gland_phen | 0.51635281 |
| 130 | MP0005623_abnormal_meninges_morphology | 0.51395124 |
| 131 | MP0003121_genomic_imprinting | 0.51338062 |
| 132 | MP0002082_postnatal_lethality | 0.50040432 |
| 133 | MP0010770_preweaning_lethality | 0.50040432 |
| 134 | MP0003183_abnormal_peptide_metabolism | 0.49557558 |
| 135 | MP0003137_abnormal_impulse_conducting | 0.48993914 |
| 136 | MP0000026_abnormal_inner_ear | 0.48908510 |
| 137 | MP0010769_abnormal_survival | 0.48727074 |
| 138 | MP0003956_abnormal_body_size | 0.48711195 |
| 139 | MP0004043_abnormal_pH_regulation | 0.48602200 |
| 140 | MP0006035_abnormal_mitochondrial_morpho | 0.48514340 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.85744400 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.97637130 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.97637130 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 5.97637130 |
| 5 | Focal seizures (HP:0007359) | 5.83186291 |
| 6 | Myokymia (HP:0002411) | 5.83045765 |
| 7 | Atonic seizures (HP:0010819) | 5.75064681 |
| 8 | Visual hallucinations (HP:0002367) | 5.38958844 |
| 9 | Febrile seizures (HP:0002373) | 5.28228336 |
| 10 | Epileptic encephalopathy (HP:0200134) | 4.97171409 |
| 11 | Hyperventilation (HP:0002883) | 4.60467712 |
| 12 | Absence seizures (HP:0002121) | 4.57524489 |
| 13 | Progressive cerebellar ataxia (HP:0002073) | 4.54161977 |
| 14 | Dialeptic seizures (HP:0011146) | 4.22947490 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 4.06402995 |
| 16 | Progressive inability to walk (HP:0002505) | 3.72877947 |
| 17 | Vacuolated lymphocytes (HP:0001922) | 3.62889061 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 3.52370139 |
| 19 | Limb dystonia (HP:0002451) | 3.49505641 |
| 20 | Pheochromocytoma (HP:0002666) | 3.36981353 |
| 21 | Broad-based gait (HP:0002136) | 3.31386408 |
| 22 | Disinhibition (HP:0000734) | 3.27315338 |
| 23 | Gaze-evoked nystagmus (HP:0000640) | 3.26196381 |
| 24 | Neuroendocrine neoplasm (HP:0100634) | 3.12854505 |
| 25 | Truncal ataxia (HP:0002078) | 3.11633981 |
| 26 | Inappropriate behavior (HP:0000719) | 3.08001711 |
| 27 | Action tremor (HP:0002345) | 3.05008038 |
| 28 | Amblyopia (HP:0000646) | 2.94039969 |
| 29 | Dysdiadochokinesis (HP:0002075) | 2.93761118 |
| 30 | Supranuclear gaze palsy (HP:0000605) | 2.92825323 |
| 31 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.92066613 |
| 32 | Abnormal eating behavior (HP:0100738) | 2.88283300 |
| 33 | Abnormal social behavior (HP:0012433) | 2.86984625 |
| 34 | Impaired social interactions (HP:0000735) | 2.86984625 |
| 35 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.86758732 |
| 36 | Loss of speech (HP:0002371) | 2.86122554 |
| 37 | Apathy (HP:0000741) | 2.84934272 |
| 38 | Inability to walk (HP:0002540) | 2.83706996 |
| 39 | Poor eye contact (HP:0000817) | 2.83243118 |
| 40 | Diplopia (HP:0000651) | 2.76519328 |
| 41 | Abnormality of binocular vision (HP:0011514) | 2.76519328 |
| 42 | Anxiety (HP:0000739) | 2.76428954 |
| 43 | Depression (HP:0000716) | 2.74181403 |
| 44 | Diminished motivation (HP:0000745) | 2.66658129 |
| 45 | Epileptiform EEG discharges (HP:0011182) | 2.65644524 |
| 46 | Dysmetria (HP:0001310) | 2.65508592 |
| 47 | Polyphagia (HP:0002591) | 2.63718158 |
| 48 | Acute necrotizing encephalopathy (HP:0006965) | 2.63651187 |
| 49 | EEG with generalized epileptiform discharges (HP:0011198) | 2.55405326 |
| 50 | Absent speech (HP:0001344) | 2.55300953 |
| 51 | Abnormality of midbrain morphology (HP:0002418) | 2.55181357 |
| 52 | Molar tooth sign on MRI (HP:0002419) | 2.55181357 |
| 53 | Excessive salivation (HP:0003781) | 2.54290217 |
| 54 | Drooling (HP:0002307) | 2.54290217 |
| 55 | Stomatitis (HP:0010280) | 2.53073820 |
| 56 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.52104431 |
| 57 | Ankle clonus (HP:0011448) | 2.51973378 |
| 58 | Failure to thrive in infancy (HP:0001531) | 2.51203178 |
| 59 | Progressive macrocephaly (HP:0004481) | 2.51114419 |
| 60 | Fetal akinesia sequence (HP:0001989) | 2.48074692 |
| 61 | Dysostosis multiplex (HP:0000943) | 2.47915176 |
| 62 | Abnormal hair whorl (HP:0010721) | 2.46383278 |
| 63 | Spastic tetraparesis (HP:0001285) | 2.46061706 |
| 64 | Cerebral inclusion bodies (HP:0100314) | 2.46060018 |
| 65 | Hypsarrhythmia (HP:0002521) | 2.43445271 |
| 66 | Scanning speech (HP:0002168) | 2.40162571 |
| 67 | Gait imbalance (HP:0002141) | 2.40011526 |
| 68 | Agnosia (HP:0010524) | 2.39597957 |
| 69 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.37872555 |
| 70 | Bradykinesia (HP:0002067) | 2.36096964 |
| 71 | Mutism (HP:0002300) | 2.34153411 |
| 72 | Insidious onset (HP:0003587) | 2.34062959 |
| 73 | Termporal pattern (HP:0011008) | 2.34062959 |
| 74 | Postural instability (HP:0002172) | 2.33181052 |
| 75 | Generalized myoclonic seizures (HP:0002123) | 2.32611661 |
| 76 | Neuronal loss in central nervous system (HP:0002529) | 2.27410191 |
| 77 | Status epilepticus (HP:0002133) | 2.27020872 |
| 78 | Genetic anticipation (HP:0003743) | 2.20001237 |
| 79 | Global brain atrophy (HP:0002283) | 2.19735247 |
| 80 | Hemiparesis (HP:0001269) | 2.15658520 |
| 81 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.15023163 |
| 82 | Gait ataxia (HP:0002066) | 2.12684041 |
| 83 | Blue irides (HP:0000635) | 2.12033225 |
| 84 | Urinary urgency (HP:0000012) | 2.11131857 |
| 85 | Papilledema (HP:0001085) | 2.10688423 |
| 86 | Impaired smooth pursuit (HP:0007772) | 2.10666602 |
| 87 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.10259638 |
| 88 | Congenital stationary night blindness (HP:0007642) | 2.10142932 |
| 89 | Poor suck (HP:0002033) | 2.10141218 |
| 90 | Congenital primary aphakia (HP:0007707) | 2.09693152 |
| 91 | Spastic gait (HP:0002064) | 2.07963173 |
| 92 | Poor head control (HP:0002421) | 2.07680251 |
| 93 | Hyperthyroidism (HP:0000836) | 2.07653923 |
| 94 | Pancreatic fibrosis (HP:0100732) | 2.06363135 |
| 95 | 3-Methylglutaconic aciduria (HP:0003535) | 2.06354583 |
| 96 | Agitation (HP:0000713) | 2.05143895 |
| 97 | Abnormal drinking behavior (HP:0030082) | 2.03880853 |
| 98 | Polydipsia (HP:0001959) | 2.03880853 |
| 99 | Mitochondrial inheritance (HP:0001427) | 2.02980872 |
| 100 | Protruding tongue (HP:0010808) | 2.02769954 |
| 101 | Retinal atrophy (HP:0001105) | 2.02571703 |
| 102 | Pancreatic cysts (HP:0001737) | 2.01751216 |
| 103 | Hemiplegia (HP:0002301) | 2.01031699 |
| 104 | Medial flaring of the eyebrow (HP:0010747) | 2.00494606 |
| 105 | Neurofibrillary tangles (HP:0002185) | 2.00068799 |
| 106 | Specific learning disability (HP:0001328) | 1.99228938 |
| 107 | Cerebral hypomyelination (HP:0006808) | 1.98354078 |
| 108 | Resting tremor (HP:0002322) | 1.97829895 |
| 109 | Type II lissencephaly (HP:0007260) | 1.96494420 |
| 110 | Esotropia (HP:0000565) | 1.96056050 |
| 111 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.96009924 |
| 112 | Upper limb muscle weakness (HP:0003484) | 1.95056904 |
| 113 | Hypothermia (HP:0002045) | 1.94498075 |
| 114 | Horizontal nystagmus (HP:0000666) | 1.94030745 |
| 115 | Delusions (HP:0000746) | 1.93275614 |
| 116 | Abnormality of the lower motor neuron (HP:0002366) | 1.92190635 |
| 117 | Acute encephalopathy (HP:0006846) | 1.91825485 |
| 118 | Impaired vibratory sensation (HP:0002495) | 1.91349401 |
| 119 | CNS hypomyelination (HP:0003429) | 1.91134001 |
| 120 | Spastic tetraplegia (HP:0002510) | 1.91119396 |
| 121 | Abnormality of the corticospinal tract (HP:0002492) | 1.90896298 |
| 122 | Psychosis (HP:0000709) | 1.90713864 |
| 123 | Focal dystonia (HP:0004373) | 1.89754099 |
| 124 | Nephrogenic diabetes insipidus (HP:0009806) | 1.89608579 |
| 125 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.89465132 |
| 126 | Delayed gross motor development (HP:0002194) | 1.88778744 |
| 127 | Hypoventilation (HP:0002791) | 1.88744474 |
| 128 | Decreased central vision (HP:0007663) | 1.88672834 |
| 129 | Tetraparesis (HP:0002273) | 1.88115900 |
| 130 | Dysmetric saccades (HP:0000641) | 1.87900455 |
| 131 | Autoimmune thrombocytopenia (HP:0001973) | 1.87653863 |
| 132 | Metaphyseal irregularity (HP:0003025) | 1.87637904 |
| 133 | Genital tract atresia (HP:0001827) | 1.87611669 |
| 134 | Vaginal atresia (HP:0000148) | 1.81238005 |
| 135 | Concave nail (HP:0001598) | 1.81060082 |
| 136 | Akinesia (HP:0002304) | 1.80911121 |
| 137 | Postural tremor (HP:0002174) | 1.80484956 |
| 138 | Intention tremor (HP:0002080) | 1.78616581 |
| 139 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.78499748 |
| 140 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.78499748 |
| 141 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.78499748 |
| 142 | Nephronophthisis (HP:0000090) | 1.78319612 |
| 143 | Stereotypic behavior (HP:0000733) | 1.77393964 |
| 144 | Tubulointerstitial fibrosis (HP:0005576) | 1.73766691 |
| 145 | Abnormality of the periventricular white matter (HP:0002518) | 1.73417833 |
| 146 | Dementia (HP:0000726) | 1.72519658 |
| 147 | Craniofacial dystonia (HP:0012179) | 1.72204357 |
| 148 | Abnormality of macrophages (HP:0004311) | 1.71820976 |
| 149 | Torticollis (HP:0000473) | 1.69117559 |
| 150 | Optic disc pallor (HP:0000543) | 1.68865682 |
| 151 | Renal Fanconi syndrome (HP:0001994) | 1.67291817 |
| 152 | Albinism (HP:0001022) | 1.65008621 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.57760636 |
| 2 | IRAK3 | 3.82004049 |
| 3 | MAP3K12 | 3.79553359 |
| 4 | MAP3K4 | 3.62888644 |
| 5 | MAP3K9 | 3.40357438 |
| 6 | MAP2K7 | 3.32669514 |
| 7 | CASK | 3.02213692 |
| 8 | EPHA4 | 2.86438614 |
| 9 | MINK1 | 2.79513296 |
| 10 | MAP2K4 | 2.50274449 |
| 11 | MARK1 | 2.32153887 |
| 12 | ACVR1B | 2.29309689 |
| 13 | PNCK | 2.24855301 |
| 14 | GRK5 | 2.11565389 |
| 15 | NTRK2 | 1.91322456 |
| 16 | PLK2 | 1.88279408 |
| 17 | NTRK1 | 1.85917401 |
| 18 | ARAF | 1.70141804 |
| 19 | STK24 | 1.67844887 |
| 20 | RIPK4 | 1.66803976 |
| 21 | DAPK2 | 1.63398367 |
| 22 | KSR2 | 1.56434016 |
| 23 | PAK6 | 1.51110552 |
| 24 | TNIK | 1.49241649 |
| 25 | MKNK2 | 1.46858522 |
| 26 | DAPK1 | 1.43885171 |
| 27 | FES | 1.40225030 |
| 28 | CDK5 | 1.40163714 |
| 29 | FRK | 1.36409258 |
| 30 | DDR2 | 1.32787552 |
| 31 | ABL2 | 1.32747353 |
| 32 | CDK19 | 1.29631775 |
| 33 | PRKCG | 1.26670372 |
| 34 | NME1 | 1.25951366 |
| 35 | BMPR1B | 1.23079618 |
| 36 | KSR1 | 1.21048220 |
| 37 | MOS | 1.17682702 |
| 38 | MAPK13 | 1.14016866 |
| 39 | CAMK2A | 1.13857826 |
| 40 | CAMKK1 | 1.11516252 |
| 41 | LATS2 | 1.08530912 |
| 42 | PRKD3 | 1.07961013 |
| 43 | PRPF4B | 1.07919098 |
| 44 | MAP4K2 | 1.01460858 |
| 45 | CAMKK2 | 0.98389656 |
| 46 | SIK2 | 0.97830676 |
| 47 | STK38 | 0.97555966 |
| 48 | AKT3 | 0.95423794 |
| 49 | PTK2B | 0.94695541 |
| 50 | CSNK1G2 | 0.94484109 |
| 51 | WNK4 | 0.93831335 |
| 52 | LMTK2 | 0.92884087 |
| 53 | PDK3 | 0.92248028 |
| 54 | PDK4 | 0.92248028 |
| 55 | LIMK1 | 0.91408619 |
| 56 | MAP3K13 | 0.90336345 |
| 57 | TSSK6 | 0.90040469 |
| 58 | CAMK2B | 0.89957084 |
| 59 | TAOK2 | 0.89198352 |
| 60 | ZAK | 0.89055566 |
| 61 | MAP3K11 | 0.88045172 |
| 62 | UHMK1 | 0.87253886 |
| 63 | PLK3 | 0.85664946 |
| 64 | ERBB4 | 0.84942765 |
| 65 | OXSR1 | 0.84600866 |
| 66 | FER | 0.84118352 |
| 67 | PRKCE | 0.83976965 |
| 68 | MATK | 0.83380797 |
| 69 | MAP3K2 | 0.83218829 |
| 70 | STK38L | 0.82291604 |
| 71 | PHKG2 | 0.81706333 |
| 72 | PHKG1 | 0.81706333 |
| 73 | PKN1 | 0.81363306 |
| 74 | CDK14 | 0.81324874 |
| 75 | SGK494 | 0.80435760 |
| 76 | SGK223 | 0.80435760 |
| 77 | CDK18 | 0.80157211 |
| 78 | MKNK1 | 0.76228038 |
| 79 | FGR | 0.76145213 |
| 80 | CDK15 | 0.75790770 |
| 81 | SGK2 | 0.74689887 |
| 82 | GRK1 | 0.73619555 |
| 83 | DYRK1A | 0.73271335 |
| 84 | MAP3K6 | 0.71780305 |
| 85 | RET | 0.70911436 |
| 86 | BMPR2 | 0.70296314 |
| 87 | CAMK1 | 0.69803689 |
| 88 | CAMK2D | 0.67419746 |
| 89 | IKBKB | 0.66211925 |
| 90 | TNK2 | 0.66148786 |
| 91 | SCYL2 | 0.64470700 |
| 92 | CDK11A | 0.64416780 |
| 93 | CAMK1D | 0.63233782 |
| 94 | PRKCH | 0.61419414 |
| 95 | GRK7 | 0.60732094 |
| 96 | IRAK2 | 0.59922698 |
| 97 | RAF1 | 0.59461134 |
| 98 | STK11 | 0.59384400 |
| 99 | CAMK2G | 0.59212346 |
| 100 | INSRR | 0.59160815 |
| 101 | TGFBR2 | 0.58172905 |
| 102 | PAK3 | 0.57637728 |
| 103 | TYRO3 | 0.56880378 |
| 104 | SIK3 | 0.56013987 |
| 105 | SGK1 | 0.55525696 |
| 106 | MAP3K1 | 0.54050419 |
| 107 | PINK1 | 0.53665307 |
| 108 | MAPKAPK5 | 0.53455020 |
| 109 | MAP3K14 | 0.52742835 |
| 110 | MAP2K1 | 0.52493961 |
| 111 | GRK6 | 0.52005342 |
| 112 | BRAF | 0.51999265 |
| 113 | MUSK | 0.51808692 |
| 114 | CSNK1G3 | 0.51246241 |
| 115 | NME2 | 0.48013335 |
| 116 | PRKG2 | 0.47736934 |
| 117 | CAMK1G | 0.46880422 |
| 118 | PDK1 | 0.46758747 |
| 119 | SGK3 | 0.46582947 |
| 120 | CSNK1G1 | 0.45409953 |
| 121 | WNK3 | 0.45094975 |
| 122 | ROCK2 | 0.44934804 |
| 123 | ALK | 0.44844414 |
| 124 | TAOK3 | 0.44586368 |
| 125 | PRKCZ | 0.44389339 |
| 126 | TRIM28 | 0.44285419 |
| 127 | TGFBR1 | 0.44021628 |
| 128 | WNK1 | 0.43377563 |
| 129 | PDK2 | 0.43236387 |
| 130 | CSNK1A1L | 0.43179001 |
| 131 | ADRBK1 | 0.42253693 |
| 132 | TLK1 | 0.42190548 |
| 133 | ADRBK2 | 0.41697987 |
| 134 | CCNB1 | 0.40190129 |
| 135 | MAP2K6 | 0.39045057 |
| 136 | PDPK1 | 0.38931383 |
| 137 | RPS6KA3 | 0.37916905 |
| 138 | PRKACA | 0.37660214 |
| 139 | CAMK4 | 0.37261335 |
| 140 | GSK3A | 0.37122815 |
| 141 | CSNK1A1 | 0.35182208 |
| 142 | DYRK3 | 0.34306039 |
| 143 | TAF1 | 0.33865016 |
| 144 | STK39 | 0.33847938 |
| 145 | DYRK2 | 0.33071965 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.09729469 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 4.04683766 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.89983168 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.89307200 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.83789218 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.62998032 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.43251548 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.41311753 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.40710658 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.39533949 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.30782070 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.28428339 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.12919945 |
| 14 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.10007273 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 2.06879737 |
| 16 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.02765164 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.02374378 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.91510956 |
| 19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.84816354 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.82807085 |
| 21 | Insulin secretion_Homo sapiens_hsa04911 | 1.79350033 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.75907319 |
| 23 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.75820037 |
| 24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.71519228 |
| 25 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.63941306 |
| 26 | Mineral absorption_Homo sapiens_hsa04978 | 1.58798830 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.57725782 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.53255603 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.50680836 |
| 30 | Renin secretion_Homo sapiens_hsa04924 | 1.49951353 |
| 31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.48053297 |
| 32 | Parkinsons disease_Homo sapiens_hsa05012 | 1.47798043 |
| 33 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.46563582 |
| 34 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.40709666 |
| 35 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.39347557 |
| 36 | Alzheimers disease_Homo sapiens_hsa05010 | 1.39316280 |
| 37 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.35885414 |
| 38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.27486973 |
| 39 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.26471576 |
| 40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.26033589 |
| 41 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.23375725 |
| 42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.17900471 |
| 43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.15885491 |
| 44 | Gap junction_Homo sapiens_hsa04540 | 1.15781247 |
| 45 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.15261119 |
| 46 | Legionellosis_Homo sapiens_hsa05134 | 1.10778393 |
| 47 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.10606425 |
| 48 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.09659795 |
| 49 | Protein export_Homo sapiens_hsa03060 | 1.07875502 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 1.05544336 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04872932 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.04855207 |
| 53 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.01971809 |
| 54 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.98673428 |
| 55 | Salmonella infection_Homo sapiens_hsa05132 | 0.96458698 |
| 56 | Huntingtons disease_Homo sapiens_hsa05016 | 0.96405661 |
| 57 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95775623 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.95390265 |
| 59 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.95225195 |
| 60 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.95206744 |
| 61 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.95036447 |
| 62 | Malaria_Homo sapiens_hsa05144 | 0.93432456 |
| 63 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.93126263 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 0.91986288 |
| 65 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.88029026 |
| 66 | Basal transcription factors_Homo sapiens_hsa03022 | 0.87691134 |
| 67 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.87417667 |
| 68 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.86023919 |
| 69 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.84628964 |
| 70 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.84578490 |
| 71 | Melanogenesis_Homo sapiens_hsa04916 | 0.83249701 |
| 72 | Glioma_Homo sapiens_hsa05214 | 0.82652956 |
| 73 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.81553381 |
| 74 | Phototransduction_Homo sapiens_hsa04744 | 0.80141315 |
| 75 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.79050088 |
| 76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.78374413 |
| 77 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.78251441 |
| 78 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.78107527 |
| 79 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.76609929 |
| 80 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.76493313 |
| 81 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.76063016 |
| 82 | Axon guidance_Homo sapiens_hsa04360 | 0.75219207 |
| 83 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.70260204 |
| 84 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.67580732 |
| 85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64897800 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64206504 |
| 87 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.64098575 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.64002989 |
| 89 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63581805 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63070248 |
| 91 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.61941507 |
| 92 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61624307 |
| 93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61436696 |
| 94 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.60369062 |
| 95 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.57513981 |
| 96 | Asthma_Homo sapiens_hsa05310 | 0.55099449 |
| 97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54123405 |
| 98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53303058 |
| 99 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.52117552 |
| 100 | Alcoholism_Homo sapiens_hsa05034 | 0.52058654 |
| 101 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51803183 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51642371 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50584745 |
| 104 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.49204658 |
| 105 | Phagosome_Homo sapiens_hsa04145 | 0.49021914 |
| 106 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.48286513 |
| 107 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.47775791 |
| 108 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46860901 |
| 109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46227958 |
| 110 | Proteasome_Homo sapiens_hsa03050 | 0.45244017 |
| 111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45202182 |
| 112 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43122033 |
| 113 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.41829272 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.40061075 |
| 115 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.39743199 |
| 116 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.38343133 |
| 117 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.37442164 |
| 118 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.37198755 |
| 119 | Leishmaniasis_Homo sapiens_hsa05140 | 0.37066264 |
| 120 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.33704529 |
| 121 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33084434 |
| 122 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31444873 |
| 123 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30538756 |
| 124 | Endocytosis_Homo sapiens_hsa04144 | 0.27930274 |
| 125 | Bile secretion_Homo sapiens_hsa04976 | 0.27693930 |
| 126 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.26168427 |
| 127 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.26160058 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26074271 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.24990406 |
| 130 | Circadian rhythm_Homo sapiens_hsa04710 | 0.24555934 |
| 131 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.23860999 |
| 132 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.23543431 |
| 133 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.22922620 |
| 134 | Melanoma_Homo sapiens_hsa05218 | 0.22507439 |
| 135 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.21793363 |
| 136 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.21389550 |
| 137 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.20443630 |
| 138 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.20405343 |
| 139 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.19751310 |
| 140 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.19660500 |

